← Eichor
Study identifier: NCT06742671 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis

Condition: Giant Cell Arteritis (GCA)  ·  Sponsor: Groupe Hospitalier de la Rochelle Ré Aunis

PhaseN/A
Planned participants100
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

Giant cell arteritis is a vasculitis, i.e. inflammation of the artery walls, which generally affects people over the age of 50. Diagnosis can be long and difficult, as the clinical signs are not specific (headache, pain in the jaw, scalp, shoulders and/or pelvis, abdominal pain, weight loss, etc.), but it must be made quickly, given the risk of complications. The reference method for diagnosis was initially based on clinical suspicion and analysis of a "piece of temporal artery" (biopsy) performed in the operating theatre under local anaesthetic. Since the mid-1990s, improvements in ultrasound techniques have made it possible to identify a sign, known as a halo, on the temporal arteries that is typical of patients with Giant Cell Arteritis. A prospective multicenter study published in 2024 demonstrated that, in patients with a clinical suspicion of Giant Cell Arteritis, if a halo was found on both temporal arteries by ultrasound, there was no need for a biopsy. This study is at the origin of a change in practices in the diagnosis and care of patients suffering from this disabling disease. To facilitate early diagnosis, a fast-track pathway has been set up. The aim is to make a rapid diagnosis, thereby reducing the risk of after-effects, shortening the length of hospital stays, considering outpatient treatment and limiting the number of biopsies. The investigators propose to evaluate the performance of this fast-track pathway.

This description comes directly from the study's public registry record.

Talk to the study team

Caroline Allix-Béguec, Ph.D.  ·  +33516494246  ·  caroline.allix-beguec@ght-atlantique17.fr

Cécile Duchiron, Ph.D.  ·  cecile.duchiron@ght-atlantique17.Fr

Always discuss trial participation with your own doctor first.

Locations (1)

Groupe Hospitalier de la Rochelle Ré AunisLa Rochelle, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06742671